Ruxolitinib is employed to treat myelofibrosis (a cancer in the bone marrow by which the bone marrow is replaced by scar tissue and triggers lessened blood mobile creation). It is additionally applied to treat polycythemia vera (PV; a slow rising cancer in the blood through which the bone marrow would https://connerkqvzc.blogozz.com/18573648/ibmx-fundamentals-explained